Lakshmi Nayak

11.4k total citations · 6 hit papers
128 papers, 5.5k citations indexed

About

Lakshmi Nayak is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Lakshmi Nayak has authored 128 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Genetics, 47 papers in Pulmonary and Respiratory Medicine and 44 papers in Neurology. Recurrent topics in Lakshmi Nayak's work include Glioma Diagnosis and Treatment (90 papers), Brain Metastases and Treatment (40 papers) and CNS Lymphoma Diagnosis and Treatment (38 papers). Lakshmi Nayak is often cited by papers focused on Glioma Diagnosis and Treatment (90 papers), Brain Metastases and Treatment (40 papers) and CNS Lymphoma Diagnosis and Treatment (38 papers). Lakshmi Nayak collaborates with scholars based in United States, Italy and United Kingdom. Lakshmi Nayak's co-authors include Patrick Y. Wen, Eudocia Q. Lee, Fábio M. Iwamoto, David A. Reardon, Lauren E. Abrey, Nils D. Arvold, Andrew D. Norden, Antonio Omuro, Manmeet S. Ahluwalia and Riccardo Soffietti and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lakshmi Nayak

119 papers receiving 5.4k citations

Hit Papers

Epidemiology of Brain Met... 2011 2026 2016 2021 2011 2019 2015 2015 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epidemiology of Brain Metastases
    2011 942 citations Lakshmi Nayak, Eudocia Q. Lee et al. Current Oncology Reports profile →
  2. Brain metastases
    2019 668 citations Riccardo Soffietti, Manmeet S. Ahluwalia et al. profile →
  3. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
    2015 471 citations Michael Weller, Raymond Y. Huang et al. profile →
  4. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
    2015 433 citations Nicholas Butowski, Howard Colman et al. Neuro-Oncology profile →
  5. PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
    2017 339 citations Lakshmi Nayak, Fábio M. Iwamoto et al. Blood profile →
  6. Primary central nervous system lymphoma
    2023 77 citations Andrés J.M. Ferreri, Jörg Dietrich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lakshmi Nayak United States 33 2.9k 2.1k 1.8k 1.3k 977 128 5.5k
Jeffrey J. Raizer United States 43 3.3k 1.1× 2.0k 0.9× 1.5k 0.8× 1.6k 1.3× 1.2k 1.3× 175 6.2k
Philippe Métellus France 38 2.2k 0.8× 1.8k 0.8× 993 0.5× 1.3k 1.0× 770 0.8× 170 5.3k
Georg Widhalm Austria 40 2.7k 0.9× 2.0k 0.9× 1.6k 0.9× 669 0.5× 301 0.3× 213 5.7k
Fábio M. Iwamoto United States 37 3.0k 1.0× 1.2k 0.6× 691 0.4× 1.4k 1.1× 886 0.9× 148 4.6k
Nina A. Paleologos United States 25 3.4k 1.2× 2.3k 1.1× 1.5k 0.8× 831 0.6× 332 0.3× 49 5.0k
Jan Drappatz United States 42 3.0k 1.1× 1.2k 0.6× 1.1k 0.6× 1.1k 0.9× 621 0.6× 155 5.3k
David M. Peereboom United States 39 2.2k 0.8× 1.7k 0.8× 1.7k 0.9× 610 0.5× 357 0.4× 198 4.8k
Enrico Franceschi Italy 38 4.1k 1.4× 2.0k 0.9× 1.2k 0.7× 809 0.6× 342 0.4× 193 5.8k
Kathryn Beal United States 34 2.2k 0.8× 2.5k 1.2× 1.7k 0.9× 464 0.4× 372 0.4× 128 4.7k
Lawrence Kleinberg United States 41 2.3k 0.8× 2.8k 1.3× 1.5k 0.8× 503 0.4× 262 0.3× 230 5.5k

Countries citing papers authored by Lakshmi Nayak

Since Specialization
Citations

This map shows the geographic impact of Lakshmi Nayak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lakshmi Nayak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lakshmi Nayak more than expected).

Fields of papers citing papers by Lakshmi Nayak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lakshmi Nayak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lakshmi Nayak. The network helps show where Lakshmi Nayak may publish in the future.

Co-authorship network of co-authors of Lakshmi Nayak

This figure shows the co-authorship network connecting the top 25 collaborators of Lakshmi Nayak. A scholar is included among the top collaborators of Lakshmi Nayak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lakshmi Nayak. Lakshmi Nayak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aquilanti, Elisa, et al.. (2024). Novel Therapies for Primary Central Nervous System Lymphomas. Current Neurology and Neuroscience Reports. 24(12). 621–629. 2 indexed citations
2.
Nayak, Lakshmi, Ugonma Chukwueke, Christopher Meehan, et al.. (2024). A pilot study of axicabtagene ciloleucel (axi-cel) for relapsed/refractory primary and secondary central nervous system lymphoma (PCNSL and SCNSL).. Journal of Clinical Oncology. 42(16_suppl). 2006–2006. 9 indexed citations
3.
Batchelor, Tracy T., Amy S. Ruppert, Susan M. Geyer, et al.. (2024). Myeloablative vs nonmyeloablative consolidation for primary central nervous system lymphoma: results of Alliance 51101. Blood Advances. 8(12). 3189–3199. 6 indexed citations
4.
Nayak, Lakshmi, Chetan Bettegowda, Florian Scherer, et al.. (2024). Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review. Neuro-Oncology. 26(6). 993–1011. 11 indexed citations
5.
Chukwueke, Ugonma, Timothy S. Sannes, Daniel Chiu, et al.. (2024). Glioma resource outreach with support: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients. Neuro-Oncology Practice. 12(1). 87–99.
6.
Ryan, Christine E., Rebecca L. Zon, Robert Redd, et al.. (2023). Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement. British Journal of Haematology. 203(5). 774–780. 8 indexed citations
7.
Deng, Davy, Gilbert Youssef, Yu‐Hui Chen, et al.. (2023). Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression. Neuro-Oncology Advances. 5(1). vdad083–vdad083. 6 indexed citations
8.
Frigault, Matthew J., Jörg Dietrich, María Martínez-Lage, et al.. (2019). Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma. Blood. 134(11). 860–866. 160 indexed citations
9.
Chukwueke, Ugonma & Lakshmi Nayak. (2019). Central Nervous System Lymphoma. Hematology/Oncology Clinics of North America. 33(4). 597–611. 19 indexed citations
10.
Torre, Matthew, Eudocia Q. Lee, Ugonma Chukwueke, et al.. (2019). Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis. Journal of the American Society of Cytopathology. 9(1). 45–54. 14 indexed citations
11.
Lee, Eudocia Q., Dan G. Duda, Alona Muzikansky, et al.. (2018). Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma. Clinical Cancer Research. 24(19). 4643–4649. 49 indexed citations
12.
Nayak, Lakshmi, John de Groot, Jeffrey S. Wefel, et al.. (2017). Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas. Journal of Neuro-Oncology. 132(1). 181–188. 23 indexed citations
13.
Nayak, Lakshmi, Fábio M. Iwamoto, Ann S. LaCasce, et al.. (2016). Nivolumab (Anti-PD1) Therapy for Relapsed/ Refractory Primary Central Nervous System Lymphoma and Primary Testicular Lymphoma. Blood. 128(22). 930–930. 4 indexed citations
14.
Reardon, David A., Lakshmi Nayak, Lisa M. DeAngelis, et al.. (2014). P15.13 * THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE: A TOOL TO ASSESS NEUROLOGIC FUNCTION FOR INTEGRATION IN THE RADIOLOGIC ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA. Neuro-Oncology. 16(suppl 2). ii76–ii76. 5 indexed citations
15.
Butowski, Nicholas, Howard Colman, John Frederick De Groot, et al.. (2014). A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma.. Journal of Clinical Oncology. 32(15_suppl). 2023–2023. 15 indexed citations
16.
Smith, Katrina H., Eudocia Q. Lee, Alona Muzikansky, et al.. (2014). Phase I study of plerixafor and bevacizumab in recurrent high-grade glioma.. Journal of Clinical Oncology. 32(15_suppl). 2031–2031. 1 indexed citations
17.
Norden, Andrew D., David Schiff, Manmeet S. Ahluwalia, et al.. (2014). Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas: Final results.. Journal of Clinical Oncology. 32(15_suppl). 2053–2053. 1 indexed citations
18.
Nayak, Lakshmi, Lauren E. Abrey, Jan Drappatz, et al.. (2012). Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma. Leukemia & lymphoma. 54(1). 58–61. 56 indexed citations
19.
Nayak, Lakshmi, Eudocia Q. Lee, & Patrick Y. Wen. (2011). Epidemiology of Brain Metastases. Current Oncology Reports. 14(1). 48–54. 942 indexed citations breakdown →
20.
Iwamoto, Fábio M., Anna R. Cooper, Anne S. Reiner, Lakshmi Nayak, & Lauren E. Abrey. (2009). Glioblastoma in the elderly. Cancer. 115(16). 3758–3766. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey J. Raizer Breakdown of academic impact, for papers by Philippe Métellus Breakdown of academic impact, for papers by Georg Widhalm Breakdown of academic impact, for papers by Fábio M. Iwamoto Breakdown of academic impact, for papers by Nina A. Paleologos Breakdown of academic impact, for papers by Jan Drappatz Breakdown of academic impact, for papers by David M. Peereboom Breakdown of academic impact, for papers by Enrico Franceschi Breakdown of academic impact, for papers by Kathryn Beal Breakdown of academic impact, for papers by Lawrence Kleinberg
Rankless by CCL
2026